-transparent.png){kind=logo}
We prepared primary monolayer cultures of adult rat hepatocytes and measured the losses of cytochromes P-450 with the use of specific antibodies directed against purified forms of hepatic cytochrome P-450 which predominate in untreated rats (P-450UT-A, P-450UT-F) or in rats treated with phenobarbital (P-450PB-B/D, P-450PB-C, P-450PB/PCN-E) or with 3-methylcholanthrene (P-450 beta NF-B, P-450 beta NF/ISF-G). In hepatocytes prepared from an untreated rat and incubated in control medium, total cytochrome P-450, measured spectrally as CO-binding hemoprotein, declined 68% during the first 72 hr in culture. However, the sum of the immunoreactive cytochromes P-450 declined only 24%, indicating that loss of heme rather than of protein accounts for much of the well-known loss of cytochromes P-450 in hepatocyte cultures. In cultures prepared from untreated rats or from rats treated with phenobarbital or with 3-methylcholanthrene, individual forms of cytochrome P-450 declined at markedly differing rates. Incubation of cultures in three different media previously reported to maintain levels of total cytochrome P-450 failed to prevent the decline in total cytochrome P-450 during the first 24 to 72 hr in culture. However, in cultures incubated in medium containing metyrapone, the level of holocytochrome P-450 was maintained at the initial value during the first 72 hr, apparently by preventing the net loss of cytochrome P-450 heme and by increasing the concentrations of immunoreactive P-450PB/PCN-E and P-450 beta NF-B. Medium containing nicotinamide increased the proportion of P-450 beta NF-B relative to the other forms of cytochrome P-450, whereas cysteine-free medium increased P-450UT-F. We conclude that loss of cytochrome P-450 in cultured hepatocytes involves loss of its heme moiety coupled with changes in the concentrations of the individual forms. Recognition of these changes as influenced by specific components of the culture medium is important when using primary hepatocyte cultures for study of xenobiotic metabolism and toxicity in the liver.
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
July 1992,
Toxicology letters,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
June 1979,
Life sciences,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
October 1979,
Life sciences,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
October 1981,
Biochemical pharmacology,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
June 1982,
Biochemical pharmacology,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
May 1982,
Proceedings of the National Academy of Sciences of the United States of America,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
February 1979,
Archives of biochemistry and biophysics,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
February 1989,
Japanese journal of cancer research : Gann,
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
September 1976,
Science (New York, N.Y.),
A R Steward, and
G A Dannan, and
P S Guzelian, and
F P Guengerich
November 1991,
In vitro cellular & developmental biology : journal of the Tissue Culture Association,
